State Street Corp Repligen Corp Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Repligen Corp stock. As of the latest transaction made, State Street Corp holds 1,691,208 shares of RGEN stock, worth $275 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,691,208

Previous 1,623,683 4.16%

Holding current value

$275 Million

Previous $242 Million 0.74%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $8.33 Million - $10.9 Million	67,525 Added 4.16%	1,691,208 $243 Million
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $13.6 Million - $19 Million	-113,741 Reduced 6.55%	1,623,683 $242 Million
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $2.49 Million - $3.8 Million	-20,788 Reduced 1.18%	1,737,424 $219 Million
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $9.32 Million - $11.4 Million	54,594 Added 3.2%	1,758,212 $323 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $5.64 Million - $9.16 Million	49,396 Added 2.99%	1,703,618 $306 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $404,127 - $513,997	2,912 Added 0.18%	1,654,222 $263 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $2.03 Million - $2.64 Million	14,647 Added 0.89%	1,651,310 $234 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $5.66 Million - $7.26 Million	36,669 Added 2.29%	1,636,663 $276 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $33.5 Million - $45.5 Million	206,414 Added 14.81%	1,599,994 $271 Million
Q3 2022 Nov 15, 2022	BUY	$160.42 - $256.21 $2.95 Million - $4.71 Million	18,369 Added 1.34%	1,393,580 $261 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $818,757 - $1.09 Million	-5,820 Reduced 0.42%	1,375,211 $223 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $5.43 Million - $8.68 Million	33,660 Added 2.5%	1,381,031 $260 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $8.61 Million - $10.6 Million	34,757 Added 2.65%	1,347,371 $357 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $318,254 - $529,759	1,634 Added 0.12%	1,312,614 $379 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $20.1 Million - $26.8 Million	121,266 Added 10.19%	1,310,980 $262 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $2.34 Million - $2.93 Million	12,958 Added 1.1%	1,189,714 $231 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $5.95 Million - $8.3 Million	40,160 Added 3.53%	1,176,756 $226 Million
Q3 2020 Nov 10, 2020	SELL	$122.51 - $158.27 $5.73 Million - $7.4 Million	-46,779 Reduced 3.95%	1,136,596 $168 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $38.2 Million - $56.9 Million	-405,273 Reduced 25.51%	1,183,375 $146 Million
Q1 2020 May 11, 2020	BUY	$84.96 - $109.14 $135 Million - $173 Million	1,588,648 New	1,588,648 $153 Million

Others Institutions Holding RGEN

# of Institutions

481

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.03B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Repligen Corp Transaction History